These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 1838804

  • 1. [Undulating course of precocious puberty].
    Kolmer M, Schulz U, Herkner K, Frisch H, Waldhauser F.
    Padiatr Padol; 1991; 26(6):271-4. PubMed ID: 1838804
    [Abstract] [Full Text] [Related]

  • 2. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF.
    N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R.
    J Clin Endocrinol Metab; 2001 Sep 24; 86(9):4127-32. PubMed ID: 11549638
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R.
    J Clin Endocrinol Metab; 2008 Jan 24; 93(1):190-5. PubMed ID: 17940112
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center.
    Chung LY, Kang E, Nam HK, Rhie YJ, Lee KH.
    J Korean Med Sci; 2021 Aug 30; 36(34):e219. PubMed ID: 34463062
    [Abstract] [Full Text] [Related]

  • 13. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB.
    J Clin Endocrinol Metab; 1999 Jan 30; 84(1):44-9. PubMed ID: 9920060
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of long-acting luteinizing-hormone-releasing hormone agonist in central precocious puberty.
    Swaenepoel C, Chaussain JL, Roger M.
    Horm Res; 1991 Jan 30; 36(3-4):126-30. PubMed ID: 1840142
    [Abstract] [Full Text] [Related]

  • 15. Follow-up of children and young adults after GnRH-agonist therapy or central precocious puberty.
    Feuillan PP, Jones JV, Barnes K, Klein KO, Cutler GB.
    J Endocrinol Invest; 2001 Oct 30; 24(9):734-6. PubMed ID: 11716160
    [No Abstract] [Full Text] [Related]

  • 16. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty.
    Oerter KE, Manasco PK, Barnes KM, Jones J, Hill S, Cutler GB.
    Acta Paediatr Suppl; 1993 Mar 30; 388():62-8; discussion 69. PubMed ID: 8329833
    [No Abstract] [Full Text] [Related]

  • 17. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.
    Bertelloni S, Baroncelli GI, Ferdeghini M, Menchini-Fabris F, Saggese G.
    Eur J Pediatr; 2000 May 30; 159(5):369-74. PubMed ID: 10834524
    [Abstract] [Full Text] [Related]

  • 18. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M, Francois R, Garandeau P, Lahlou N, Morel Y.
    J Clin Endocrinol Metab; 1986 Apr 30; 62(4):670-7. PubMed ID: 2936759
    [Abstract] [Full Text] [Related]

  • 19. Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty.
    Lin TH, LePage ME, Henzl M, Kirkland JL.
    J Pediatr; 1986 Dec 30; 109(6):954-8. PubMed ID: 2946840
    [Abstract] [Full Text] [Related]

  • 20. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM, Comite F, Pescovitz OH, Ross JL, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1984 Oct 30; 59(4):801-5. PubMed ID: 6434582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.